hers glp-1 injections Hims & Stock Plummets. The Wegovy Shortage Is Over Hers | Women's Healthcare, Online

One recent study in patients with psoriasis and psoriatic arthritis found that overweight individuals who combined a GLP-1 agonist with an anti-IL-17 medication experienced both weight loss and improved disease control compared to those using immunosuppressive therapy alone

But its size and matched comparison design make the findings more reliable than earlier isolated reports of GLP-1s and hair loss, says Friedman

The study enrolled 411 adult participants with type 2 diabetes

The segment is supported by growing consumer awareness of GLP-1 medications through social media and direct-to-consumer marketing that has created strong patient demand